Mirum Pharmaceuticals Inc (MIRM)
46.26
+2.34
(+5.33%)
USD |
NASDAQ |
Nov 14, 16:00
46.46
+0.20
(+0.43%)
After-Hours: 20:00
Mirum Pharmaceuticals Gross Profit (Annual): 139.34M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 139.34M |
| December 31, 2022 | 64.69M |
| Date | Value |
|---|---|
| December 31, 2021 | 17.24M |
| December 31, 2020 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
2020
139.34M
Maximum
2023
55.31M
Average
40.96M
Median
Gross Profit (Annual) Benchmarks
| Arcutis Biotherapeutics Inc | 54.62M |
| Cytokinetics Inc | -322.59M |
| Amicus Therapeutics Inc | 362.03M |
| MannKind Corp | 136.19M |
| TG Therapeutics Inc | 219.53M |